Pei‐Hui Wang
Hebei Medical University(CN)Zhejiang Chinese Medical University(CN)Weifang Medical University(CN)Shandong University(CN)Guangxi Medical University(CN)Nantong University(CN)Peking University(CN)Beijing Jiaotong University(CN)Kunming Medical University(CN)Suizhou Central Hospital(CN)Second Hospital of Shandong University(CN)Zhuhai People's Hospital(CN)Yancheng First People's Hospital(CN)First Affiliated Hospital of Kunming Medical University(CN)Ministry of Education(PT)Chongqing Medical University(CN)University of Hong Kong(HK)
Publications by Year
Research Areas
interferon and immune responses, SARS-CoV-2 and COVID-19 Research, Invertebrate Immune Response Mechanisms, COVID-19 Clinical Research Studies, Aquaculture disease management and microbiota
Most-Cited Works
- → SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70(2020)369 cited
- → ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation(2020)360 cited
- → Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling(2020)299 cited
- → SARS‐CoV‐2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG‐I/MDA‐5–MAVS, TLR3–TRIF, and cGAS–STING signaling pathways(2021)241 cited
- → Molecular cloning, characterization and expression analysis of two novel Tolls (LvToll2 and LvToll3) and three putative Spätzle-like Toll ligands (LvSpz1–3) from Litopenaeus vannamei(2011)238 cited
- → SARS-CoV-2 spike promotes inflammation and apoptosis through autophagy by ROS-suppressed PI3K/AKT/mTOR signaling